RESOURCES

For Translational Insights in Metabolic Discovery and Development

Class B GPCR Target Significance

Dose-response Relationships Across Clinically Relevant Human Targets

Assessing Fcγ receptor (FcγR) binding is an essential part of therapeutic antibody characterization, as these interactions influence a molecule’s effector function, safety profile, and mechanism of action.

The growing global burden of neurological disorders, driven by aging populations and environmental factors, has renewed interest in this area with a focus on neuroinflammation and neurodegeneration.

Accelerate Timelines and Gather Valuable Data with a Proven and Established Portfolio of Assays and Analytical Tools

Explore Eurofins Discovery’s comprehensive CRO chemistry services, spanning Medicinal, Synthetic, Computational, and Analytical chemistry, from small-scale synthesis to full process development to enable rapid design-make-test-analyze (DMTA) cycles and accelerate your drug discovery programs.

Successful Translational Approach to Accelerate Discovery Programs

Streamline. Automate. Accelerate.

Eurofins Discovery’s SAFETYscan^®47 DataViz is a complementary, customizable and interactive dashboard designed to extract, visualize, and communicate SAFETYscan47 in vitro safety pharmacology results.

Number of Active Predictions

Scalable, Affordable, Adaptable Kinase Solutions